QuidelOrtho Corp
For the period ended Dec 28, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
QDEL$11.52-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Loss
(In millions, except per share data)
| Fiscal Year Ended | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Total revenues | $2,730.2 | $2,782.9 | $2,997.8 |
| Cost of sales, excluding amortization of intangibles | 1,456.0 | 1,496.4 | 1,500.7 |
| Selling, marketing and administrative | 746.3 | 766.8 | 763.2 |
| Research and development | 186.2 | 218.7 | 245.0 |
| Amortization of intangible assets | 189.2 | 203.4 | 204.8 |
| Restructuring, integration and other charges | 263.6 | 127.2 | 113.4 |
| Goodwill impairment charge | 700.7 | 1,822.6 | — |
| Asset impairment charge | 9.7 | 56.9 | 4.5 |
| Other operating expenses | 97.7 | 51.8 | 27.1 |
| Operating (loss) income | (919.2) | (1,960.9) | 139.1 |
| Interest expense, net | 177.6 | 163.5 | 147.6 |
| Loss on extinguishment of debt | 5.1 | — | — |
| Other expense, net | 5.8 | 7.1 | 20.6 |
| Loss before income taxes | (1,107.7) | (2,131.5) | (29.1) |
| Provision for (benefit from) income taxes | 24.1 | (79.5) | (19.0) |
| Net loss | $(1,131.8) | $(2,052.0) | $(10.1) |
| Basic loss per share | $(16.69) | $(30.54) | $(0.15) |
| Diluted loss per share | $(16.69) | $(30.54) | $(0.15) |
| Weighted-average shares outstanding - basic | 67.8 | 67.2 | 66.8 |
| Weighted-average shares outstanding - diluted | 67.8 | 67.2 | 66.8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.